Page 14 - SaxoCell Annual Report 2021

Technical University Dresden

Technical University Dresden (TUD) has its roots in the Royal Saxon Technical School that was
founded in 1828. Today, it is a university that unites the natural and engineering sciences with the
humanities and social sciences, as well as medicine. This wide range of disciplines brings with it the
obligation for the university to promote interdisciplinarity and to contribute to the integration of
science and society. The TUD is one of the largest “Technical Universities” in Germany and one of the
leading and most dynamic universities in Germany. As a full-curriculum university with 17 faculties in
SaxoCell Core Institutions Mobility & Environment as well as Culture & Societal Change and these are considered exemplary in
five schools, it offers a broad variety of 124 disciplines. It focuses on Health Sciences, Biomedicine &
Bioengineering, Information Technology & Microelectronics, Smart Materials & Structures, Energy,

Germany and throughout Europe. Around 32,000 students are enrolled at TUD, one in eight coming
from abroad. TUD is among the 20 most innovative universities in Europe (Reuters Top 100: Europe’s
Most Innovative Universities) starting around 20 spin-off companies per year. It has a total budget of
approx. EUR 578 million thereof approx. 46% third-party funded.

Since 2012, TUD has been one of Germany’s Universities of Excellence. The Center for Regenerative
Therapies Dresden (CRTD) was funded by the DFG as Research Centre and Cluster of Excellence,
which among other things develops cell therapy for immune modulation and tissue replacement. The
CRTD faculty currently includes two Alexander von Humboldt professors. Dresden university hospital,
has many years of expertise in the field of 'investigator-initiated' and third-party clinical trials and is
specialised in the application of ATMPs. This includes comprehensive immune monitoring and
biomarker screening as well as biobanking of all types of tissue and liquid samples. It has extensive
experience and scientific expertise in the field of haematopoietic stem cell transplantation and CAR-T
cell application and production.

9